$14 Billion Virtual Reality (VR) Neuropsychological Therapy Market (2024-2034) by Technology, Offering, End-user and Region Featuring Profiles of Oculus VR (Facebook Technologies), MindMaze, Psious, and More
June 07, 2024 04:19 ET
|
Research and Markets
Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Global Virtual Reality Neuropsychological Therapy Market" report has been added to ResearchAndMarkets.com's offering.The global virtual reality...
BioNTX Announces 10th Annual iC³® Life Science & Healthcare Innovation Summit
June 06, 2024 10:00 ET
|
Bio North Texas
BioNTX, the leading biotechnology trade organization in North Texas, is thrilled to announce the 10th Annual iC³® Life Science Summit.
Assembly Biosciences Presents New Data Highlighting Hepatitis D Virus Entry Inhibitor ABI-6250 at the EASL Congress™ 2024
June 05, 2024 08:00 ET
|
Assembly Biosciences, Inc.
-- Poster highlights promising preclinical profile of ABI-6250 ahead of entry into the clinic, expected by end of 2024 -- SOUTH SAN FRANCISCO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- Assembly...
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
June 05, 2024 07:00 ET
|
CytoSorbents
CytoSorbents to Host its 2024 Virtual Annual Stockholders Meeting
Lumos Pharma Announces New Analyses of Phase 2 OraGrowtH212 Trial Presented at ENDO 2024
June 04, 2024 09:00 ET
|
Lumos Pharma, Inc.
AUSTIN, Texas, June 04, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma, Inc. (NASDAQ:LUMO), a clinical-stage biopharmaceutical company focused on therapeutics for rare diseases, announced today details of...
CytoSorbents STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024. Named Top Five Finalist for Best Scientific Abstract
June 04, 2024 07:00 ET
|
CytoSorbents
CTSO STAR Registry Data on Patients on Ticagrelor Undergoing CABG Surgery with CytoSorb Presented at EuroPCR 2024
SYS6002 (CRB-701) A Next-Generation Nectin-4 Targeting Antibody Drug Conjugate Continues to Demonstrate Encouraging Safety and Efficacy Observed in Patients with Nectin-4 Positive Tumors in a Clinical Update Presented at ASCO 2024
June 01, 2024 10:00 ET
|
Corbus Pharmaceuticals Holdings, Inc.
An additional 19 patients have been enrolled since January 2024 bringing the total to 37 of whom 25 were evaluable for efficacySYS6002 (CRB-701) demonstrated 44% ORR and 78% DCR in mUC and 43% ORR and...
Lynch Carpenter Investigates Claims in Sav-RX Data Breach
May 31, 2024 17:21 ET
|
Lynch Carpenter
PITTSBURGH, May 31, 2024 (GLOBE NEWSWIRE) -- Sav-Rx recently announced that it suffered from a cybersecurity attack in October of 2023, which impacted the personal information of approximately 2.8...
Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034: Rising Opportunities for IBD Drugs in Asian Markets
May 31, 2024 06:32 ET
|
Research and Markets
Dublin, May 31, 2024 (GLOBE NEWSWIRE) -- The "Inflammatory Bowel Diseases (IBD) Drugs Market Report 2024-2034" has been added to ResearchAndMarkets.com's offering.World revenue for the Inflammatory...
QIAGEN and Myriad Genetics develop distributable homologous recombination deficiency test for global research and companion diagnostics applications
May 30, 2024 17:55 ET
|
Myriad Genetics, Inc.
Next-generation-sequencing-based homologous recombination deficiency (HRD) assay based on QIAGEN’s QIAseq xHYB technology, QIAGEN Digital Insight solutions, and Myriad’s proprietary, FDA-approved...